查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1609665

2025-2033 年日本体外诊断市场报告（按测试类型、产品、可用性、应用、最终用户和地区）

Japan In Vitro Diagnostics Market Report by Test Type, Product, Usability, Application, End User, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 115 Pages | 商品交期: 5-7个工作天内

价格
简介目录

2024年日本体外诊断市场IMARC Group达50亿美元。老年人口的增加、技术的快速进步、医疗保健意识的增强、政府倡议的增加、个人化药物的开发、对研发（R＆D）活动的​​重视是推动市场的一些关键因素。

体外诊断 (IVD) 是使用人体生物样本进行的一系列医学测试。这些测试透过分析生物体外部的血液、尿液或组织样本来检测疾病、感染和其他医疗状况。它们用于实验室、医院和专科诊所，对于医疗决策、病患监测和个人化治疗至关重要。 IVD 在医疗保健领域的日益普及支持早期诊断和精确治疗，使医疗保健提供者能够做出明智、及时的决策。作为现代医疗保健系统的重要组成部分，体外诊断有助于促进预防和治疗护理的进步，并提高患者的整体福祉。它还提高了医疗保健效率，促进早期发现并降低医疗保健成本。它也用于监测慢性疾病和协助治疗决策。

日本体外诊断市场趋势：

老年人口的增加需要更全面和常规的医学检测，这是促进市场成长的主要因素之一。与此一致的是，糖尿病、心血管疾病和癌症等与年龄相关的疾病的盛行率不断增加，促使越来越多的 IVD 测试来诊断和管理这些疾病，从而推动了市场的成长。此外，IVD 技术的快速进步正在引入更高精度和更有效率的创新解决方案，例如分子诊断、即时护理 (POC) 测试和自动化技术的创新，从而提高了 IVD 测试的精确度、速度和可及性，也为市场成长创造了积极的前景。除此之外，越来越多的政府措施促进医疗保健创新以及推出用户友好的个人化 IVD 解决方案也对市场成长产生了积极影响。此外，随着消费者越来越主动地管理自己的健康，人们对预防性医疗保健的认识和重视不断增强，导致对健康相关诊断测试和个人化医疗解决方案的需求更高，这也是一个增长诱导因素。此外，个人化医疗的突然转变和分子诊断的发展正在塑造日本 IVD 市场的未来。除此之外，对研发（R＆D）的日益关注以及诊断公司和研究机构之间的合作伙伴关係正在为市场提供有利可图的成长机会。除此之外，巨量资料和人工智慧（AI）在诊断、增强分析能力和个人化护理方面的整合正在为市场成长提供有利可图的机会。

日本体外诊断市场细分：

测试类型见解：

  • 临床化学
  • 分子诊断
  • 免疫诊断
  • 血液学
  • 其他的

产品见解：

  • 试剂和试剂盒
  • 仪器仪表

可用性见解：

  • 免洗体外诊断设备
  • 可重复使用的 IVD 设备

应用见解：

  • 传染病
  • 糖尿病
  • 癌症/肿瘤学
  • 心臟病学
  • 自体免疫疾病
  • 肾臟病学
  • 其他的

最终使用者见解：

  • 医院实验室
  • 临床实验室
  • 即时检测中心
  • 学术机构
  • 患者
  • 其他的

本报告回答的关键问题：

  • 日本体外诊断市场迄今表现如何，未来几年将如何表现？
  • COVID-19 对日本体外诊断市场有何影响？
  • 日本体外诊断市场依测试类型划分是怎样的？
  • 日本体外诊断市场依产品划分是怎样的？
  • 日本体外诊断市场在可用性方面的分化如何？
  • 日本体外诊断市场依应用划分是怎样的？
  • 日本体外诊断市场的最终用户细分如何？
  • 日本体外诊断市场价值链的各个阶段是什么？
  • 日本体外诊断市场的关键驱动因素和挑战是什么？
  • 日本体外诊断市场的结构如何？
  • 日本体外诊断市场的竞争程度如何？

本报告回答的关键问题：

  • 日本体外诊断市场迄今表现如何，未来几年将如何表现？
  • COVID-19 对日本体外诊断市场有何影响？
  • 日本体外诊断市场依测试类型划分是怎样的？
  • 日本体外诊断市场依产品划分是怎样的？
  • 日本体外诊断市场在可用性方面的分化如何？
  • 日本体外诊断市场依应用划分是怎样的？
  • 日本体外诊断市场的最终用户细分如何？
  • 日本体外诊断市场价值链的各个阶段是什么？
  • 日本体外诊断市场的关键驱动因素和挑战是什么？
  • 日本体外诊断市场的结构如何？
  • 日本体外诊断市场的竞争程度如何？

目录

第一章：前言

第 2 章：范围与方法

  • 研究目的
  • 利害关係人
  • 数据来源
    • 主要来源
    • 二手资料
  • 市场预测
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第 3 章：执行摘要

第 4 章：日本体外诊断市场 - 简介

  • 概述
  • 市场动态
  • 产业动态
  • 竞争情报

第 5 章：日本体外诊断市场格局

  • 历史与当前市场趋势（2019-2024）
  • 市场预测（2025-2033）

第 6 章：日本体外诊断市场 - 细分：按测试类型

  • 临床化学
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 分子诊断
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 免疫诊断
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 血液学
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 其他的
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）

第 7 章：日本体外诊断市场 - 细分：依产品分类

  • 试剂和试剂盒
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 仪器仪表
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）

第 8 章：日本体外诊断市场 - 细分：按可用性划分

  • 免洗体外诊断设备
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 可重复使用的 IVD 设备
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）

第 9 章：日本体外诊断市场 - 细分：按应用分类

  • 传染病
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 糖尿病
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 癌症/肿瘤学
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 心臟病学
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 自体免疫疾病
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 肾臟病学
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 其他的
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）

第 10 章：日本体外诊断市场 - 细分：依最终用户划分

  • 医院实验室
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 临床实验室
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 即时检测中心
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 学术机构
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 患者
    • 概述
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）
  • 其他的
    • 历史与当前市场趋势（2019-2024）
    • 市场预测（2025-2033）

第 11 章：日本体外诊断市场 - 竞争格局

  • 概述
  • 市场结构
  • 市场参与者定位
  • 最佳制胜策略
  • 竞争仪表板
  • 公司评估象限

第 12 章：关键参与者简介

  • Company A
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Product Portfolio
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 13 章：日本体外诊断市场 - 产业分析

  • 驱动因素、限制因素和机会
    • 概述
    • 司机
    • 限制
    • 机会
  • 波特五力分析
    • 概述
    • 买家的议价能力
    • 供应商的议价能力
    • 竞争程度
    • 新进入者的威胁
    • 替代品的威胁
  • 价值链分析

第 14 章：附录

简介目录
Product Code: SR112024A11064

The Japan in vitro diagnostics market size reached USD 5.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 6.21 Billion by 2033, exhibiting a growth rate (CAGR) of 2.4% during 2025-2033. The rising geriatric population, rapid technological advancements, growing healthcare awareness, increasing government initiatives, development of personalized medication, enhanced focus on research and development (R&D) activities represent some of the key factors driving the market.

In vitro diagnostics (IVD) is a collection of medical tests performed using biological samples from the human body. These tests detect diseases, infections, and other medical conditions by analyzing blood, urine, or tissue samples outside the living organism. They are utilized in laboratories, hospitals, and specialized clinics and are vital in medical decision-making, patient monitoring, and personalized treatment. The increasing adoption of IVD in healthcare supports early diagnosis and precise treatment, allowing healthcare providers to make informed and timely decisions. As an essential component of modern healthcare systems, IVD contributes to the advancement of preventive and therapeutic care, enhancing overall patient well-being. It also improves healthcare efficiency, promoting early detection and reducing healthcare costs. It is also employed in monitoring chronic illnesses and assisting in therapeutic decision-making.

Japan In Vitro Diagnostics Market Trends:

The rising geriatric population necessitating more comprehensive and routine medical testing is one of the major factors contributing to the market growth. In line with this, the increasing prevalence of age-related diseases, such as diabetes, cardiovascular conditions, and cancer, prompting increased IVD tests to diagnose and manage these ailments, is propelling the market growth. Additionally, rapid technological advancements in IVD that are introducing innovative solutions with higher accuracy and efficiency, such as innovations in molecular diagnostics, point-of-care (POC) testing, and automation technologies, enhancing the precision, speed, and accessibility of IVD tests, are also creating a positive outlook for the market growth. In addition to this, the increasing government initiatives promoting healthcare innovation and the introduction of user-friendly, personalized IVD solutions are also positively impacting the market growth. Moreover, the growing awareness and emphasis on preventive healthcare as consumers are increasingly proactive in managing their health, leading to higher demand for wellness-related diagnostic tests and personalized medicine solutions, is acting as a growth-inducing factor. Furthermore, the sudden shift towards personalized medicine and the development of molecular diagnostics are shaping the future of the IVD market in Japan. Besides this, the increasing focus on research and development (R&D) and partnerships between diagnostics companies and research institutions are providing remunerative growth opportunities for the market. In addition to this, the integration of big data and artificial intelligence (AI) in diagnostics, enhancing analytical capabilities, and personalizing care is providing remunerative opportunities for the market growth.

Japan In Vitro Diagnostics Market Segmentation:

Test Type Insights:

  • Clinical Chemistry
  • Molecular Diagnostics
  • Immunodiagnostics
  • Hematology
  • Others

Product Insights:

  • Reagents and Kits
  • Instruments

Usability Insights:

  • Disposable IVD Devices
  • Reusable IVD Devices

Application Insights:

  • Infectious Disease
  • Diabetes
  • Cancer/Oncology
  • Cardiology
  • Autoimmune Disease
  • Nephrology
  • Others

End User Insights:

  • Hospitals Laboratories
  • Clinical Laboratories
  • Point-Of-Care Testing Centers
  • Academic Institutes
  • Patients
  • Others

Competitive Landscape:

  • The report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan in vitro diagnostics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan in vitro diagnostics market?
  • What is the breakup of the Japan in vitro diagnostics market on the basis of test type?
  • What is the breakup of the Japan in vitro diagnostics market on the basis of product?
  • What is the breakup of the Japan in vitro diagnostics market on the basis of usability?
  • What is the breakup of the Japan in vitro diagnostics market on the basis of application?
  • What is the breakup of the Japan in vitro diagnostics market on the basis of end user?
  • What are the various stages in the value chain of the Japan in vitro diagnostics market?
  • What are the key driving factors and challenges in the Japan in vitro diagnostics market?
  • What is the structure of the Japan in vitro diagnostics market and who are the key players?
  • What is the degree of competition in the Japan in vitro diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan In Vitro Diagnostics Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan In Vitro Diagnostics Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan In Vitro Diagnostics Market - Breakup by Test Type

  • 6.1 Clinical Chemistry
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Forecast (2025-2033)
  • 6.2 Molecular Diagnostics
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Forecast (2025-2033)
  • 6.3 Immunodiagnostics
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2019-2024)
    • 6.3.3 Market Forecast (2025-2033)
  • 6.4 Hematology
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2019-2024)
    • 6.4.3 Market Forecast (2025-2033)
  • 6.5 Others
    • 6.5.1 Historical and Current Market Trends (2019-2024)
    • 6.5.2 Market Forecast (2025-2033)

7 Japan In Vitro Diagnostics Market - Breakup by Product

  • 7.1 Reagents and Kits
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Instruments
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)

8 Japan In Vitro Diagnostics Market - Breakup by Usability

  • 8.1 Disposable IVD Devices
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Reusable IVD Devices
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)

9 Japan In Vitro Diagnostics Market - Breakup by Application

  • 9.1 Infectious Disease
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2019-2024)
    • 9.1.3 Market Forecast (2025-2033)
  • 9.2 Diabetes
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2019-2024)
    • 9.2.3 Market Forecast (2025-2033)
  • 9.3 Cancer/Oncology
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2019-2024)
    • 9.3.3 Market Forecast (2025-2033)
  • 9.4 Cardiology
    • 9.4.1 Overview
    • 9.4.2 Historical and Current Market Trends (2019-2024)
    • 9.4.3 Market Forecast (2025-2033)
  • 9.5 Autoimmune Disease
    • 9.5.1 Overview
    • 9.5.2 Historical and Current Market Trends (2019-2024)
    • 9.5.3 Market Forecast (2025-2033)
  • 9.6 Nephrology
    • 9.6.1 Overview
    • 9.6.2 Historical and Current Market Trends (2019-2024)
    • 9.6.3 Market Forecast (2025-2033)
  • 9.7 Others
    • 9.7.1 Historical and Current Market Trends (2019-2024)
    • 9.7.2 Market Forecast (2025-2033)

10 Japan In Vitro Diagnostics Market - Breakup by End User

  • 10.1 Hospitals Laboratories
    • 10.1.1 Overview
    • 10.1.2 Historical and Current Market Trends (2019-2024)
    • 10.1.3 Market Forecast (2025-2033)
  • 10.2 Clinical Laboratories
    • 10.2.1 Overview
    • 10.2.2 Historical and Current Market Trends (2019-2024)
    • 10.2.3 Market Forecast (2025-2033)
  • 10.3 Point-of-care Testing Centers
    • 10.3.1 Overview
    • 10.3.2 Historical and Current Market Trends (2019-2024)
    • 10.3.3 Market Forecast (2025-2033)
  • 10.4 Academic Institutes
    • 10.4.1 Overview
    • 10.4.2 Historical and Current Market Trends (2019-2024)
    • 10.4.3 Market Forecast (2025-2033)
  • 10.5 Patients
    • 10.5.1 Overview
    • 10.5.2 Historical and Current Market Trends (2019-2024)
    • 10.5.3 Market Forecast (2025-2033)
  • 10.6 Others
    • 10.6.1 Historical and Current Market Trends (2019-2024)
    • 10.6.2 Market Forecast (2025-2033)

11 Japan In Vitro Diagnostics Market - Competitive Landscape

  • 11.1 Overview
  • 11.2 Market Structure
  • 11.3 Market Player Positioning
  • 11.4 Top Winning Strategies
  • 11.5 Competitive Dashboard
  • 11.6 Company Evaluation Quadrant

12 Profiles of Key Players

  • 12.1 Company A
    • 12.1.1 Business Overview
    • 12.1.2 Product Portfolio
    • 12.1.3 Business Strategies
    • 12.1.4 SWOT Analysis
    • 12.1.5 Major News and Events
  • 12.2 Company B
    • 12.2.1 Business Overview
    • 12.2.2 Product Portfolio
    • 12.2.3 Business Strategies
    • 12.2.4 SWOT Analysis
    • 12.2.5 Major News and Events
  • 12.3 Company C
    • 12.3.1 Business Overview
    • 12.3.2 Product Portfolio
    • 12.3.3 Business Strategies
    • 12.3.4 SWOT Analysis
    • 12.3.5 Major News and Events
  • 12.4 Company D
    • 12.4.1 Business Overview
    • 12.4.2 Product Portfolio
    • 12.4.3 Business Strategies
    • 12.4.4 SWOT Analysis
    • 12.4.5 Major News and Events
  • 12.5 Company E
    • 12.5.1 Business Overview
    • 12.5.2 Product Portfolio
    • 12.5.3 Business Strategies
    • 12.5.4 SWOT Analysis
    • 12.5.5 Major News and Events

13 Japan In Vitro Diagnostics Market - Industry Analysis

  • 13.1 Drivers, Restraints, and Opportunities
    • 13.1.1 Overview
    • 13.1.2 Drivers
    • 13.1.3 Restraints
    • 13.1.4 Opportunities
  • 13.2 Porters Five Forces Analysis
    • 13.2.1 Overview
    • 13.2.2 Bargaining Power of Buyers
    • 13.2.3 Bargaining Power of Suppliers
    • 13.2.4 Degree of Competition
    • 13.2.5 Threat of New Entrants
    • 13.2.6 Threat of Substitutes
  • 13.3 Value Chain Analysis

14 Appendix